Has anyone transitioned to the U-500 KwikPens at your facility since the discontinuation of the vial?

If so, I’d appreciate learning more about:

- Risk‑mitigating strategies implemented during and after the transition

- Nursing education and rollout approach (e.g., is education provided with each dispense)
- Pen needle supply – who provides them (pharmacy vs. unit supply)

- Storage and handling of pens once dispensed to the patient care area

- Auditing and monitoring processes used post‑implementation

Any lessons learned, challenges encountered, or recommendations would be extremely helpful. Thank you in advance for sharing your experiences!